Selected article for: "cc NC ND International license and linear model"

Author: Janice M Leung; Chen Xi Yang; Anthony Tam; Tawimas Shaipanich; Tillie L Hackett; Gurpreet K Singhera; Delbert R Dorscheid; Don D Sin
Title: ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19
  • Document date: 2020_3_23
  • ID: ei2b8oqn_26
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.18.20038455 doi: medRxiv preprint The red box indicates the median and the interquartile range. The P-value was obtained from the robust linear model Abbreviations: ACE-2, angiotensin converting enzyme II; COPD, chronic obstructive pulmonary disease; CPM, counts per million reads . CC-BY-NC-ND 4.0 International license It is made availabl.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.18.20038455 doi: medRxiv preprint The red box indicates the median and the interquartile range. The P-value was obtained from the robust linear model Abbreviations: ACE-2, angiotensin converting enzyme II; COPD, chronic obstructive pulmonary disease; CPM, counts per million reads . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • angiotensin enzyme II converting and chronic obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • angiotensin enzyme II converting and enzyme II converting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • angiotensin enzyme II converting and International license: 1, 2, 3, 4
    • angiotensin enzyme II converting and interquartile range: 1, 2, 3, 4, 5, 6
    • angiotensin enzyme II converting and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • angiotensin enzyme II converting and pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cc NC ND International license and chronic obstructive pulmonary disease: 1, 2, 3, 4
    • cc NC ND International license and enzyme II converting: 1, 2, 3, 4
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and interquartile range: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and linear model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cc NC ND International license and obstructive pulmonary disease: 1, 2, 3, 4
    • cc NC ND International license and pulmonary disease: 1, 2, 3, 4, 5, 6, 7
    • chronic obstructive pulmonary disease and enzyme II converting: 1, 2, 3, 4, 5, 6, 7, 8
    • chronic obstructive pulmonary disease and International license: 1, 2, 3, 4
    • chronic obstructive pulmonary disease and interquartile range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • chronic obstructive pulmonary disease and linear model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • chronic obstructive pulmonary disease and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic obstructive pulmonary disease and pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25